Development of FRET Biosensor to Characterize CSK Subcellular Regulation

Area of Science:

• Cell Biology
• Biochemistry
• Molecular Biology

Background:

• C-terminal Src kinase (CSK) inhibits Src family kinases (SFKs) by phosphorylating their C-tail.
• CSK localization to the plasma membrane is crucial for SFK regulation, but mechanisms remain unclear.
• Understanding CSK activity and localization is vital for cellular regulation.

Purpose of the Study:

• To develop a genetically encoded FRET biosensor for visualizing CSK activity in live cells.
• To investigate CSK's subcellular localization and activity in different membrane microregions.
• To explore factors influencing CSK activity, such as PTPα.

Main Methods:

• Development of a FRET-based biosensor with an optimized substrate peptide.
• Utilizing the biosensor to measure CSK activity in live cells, including airway smooth muscle cells.
• Employing submembrane-targeting signals to localize CSK activity to lipid raft and non-lipid raft microregions.

Main Results:

• The FRET biosensor demonstrated specificity and sensitivity to CSK activity, with minor responses to Src and Fyn.
• CSK activity was detected in both non-lipid raft and lipid raft microregions, with higher levels in non-lipid areas.
• Receptor-type protein tyrosine phosphatase alpha (PTPα) inhibited CSK FRET response; no significant CSK activity difference was found between metastatic and normal cancer cells.

Conclusions:

• A novel FRET biosensor enables real-time monitoring of CSK activity.
• CSK activity is present in both non-lipid and lipid raft membrane microregions, predominantly in non-lipid areas.
• The study provides insights into CSK regulation and localization, crucial for understanding SFK signaling pathways.